Microbix Biosystems (TSE:MBX) Reaches New 1-Year High – Here’s Why

Microbix Biosystems Inc. (TSE:MBX) shares reached a new 52-week high during trading on Wednesday . The stock traded as high as C$0.50 and last traded at C$0.50, with a volume of 1457199 shares trading hands. The stock had previously closed at C$0.44.

Microbix Biosystems Trading Up 19.5 %

The company has a quick ratio of 5.57, a current ratio of 6.62 and a debt-to-equity ratio of 22.68. The company has a market cap of C$71.08 million, a price-to-earnings ratio of 13.00 and a beta of 0.34. The business has a fifty day simple moving average of C$0.37 and a 200 day simple moving average of C$0.35.

Microbix Biosystems Company Profile

Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.